Clinical Trial Update: Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

View source ↗

Summary

A Guidant-sponsored multicenter trial of the Cognis Teligen 100 HE and Reliance quadripolar defibrillation lead (4-site field following) has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: Guidant Corporation | Conditions: Ventricular Tachycardia, Ventricular Fibrillation, Heart Failure | Status: COMPLETED